Harmony TPV System
Medtronic, Inc. · Decision date Mar 26, 2021
What did the FDA approve?
FDA approved the Harmony Transcatheter Pulmonary Valve System from Medtronic, Inc. on March 26, 2021, under PMA number P200046. The approval covers management of pediatric and adult patients with severe pulmonary regurgitation who have a native or surgically-repaired right ventricular outflow tract and are clinically indicated for surgical pulmonary valve replacement.
The indication defines severe pulmonary regurgitation as determined by echocardiography and/or a pulmonary regurgitant fraction of 30% or more as determined by cardiac magnetic resonance imaging. The device is categorized as a percutaneously delivered pulmonary valve prosthesis under product code NPV. The record does not state whether this decision is an original PMA or a supplement, and no supplement type or reason is provided.
FDA approval order statement
Approval for the Harmony Transcatheter Pulmonary Valve (TPV) System. This device is indicated for use in the management of pediatric and adult patients with severe pulmonary regurgitation (i.e., severe pulmonary regurgitation as determined by echocardiography and/or pulmonary regurgitant fraction >= 30% as determined by cardiac magnetic resonance imaging) who have a native or surgically-repaired right ventricular outflow tract and are clinically indicated for surgical pulmonary valve replacement.
- Regulatory pathway
- Original PMA
- Clinical specialty
- Cardiovascular
- Decision date
- Mar 26, 2021
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P200046
- Regulatory pathway
- Premarket approval application
- Applicant
- Medtronic, Inc.
- Product code
- NPV
- Decision code
- APPR
- Decision date
- Mar 26, 2021
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Pulmonary valve prosthesis percutaneously delivered.
- Applicant
- Medtronic, Inc.
- Product code
- NPV
- FDA device class
- f
The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.
FDA decision timeline
P200046 received
Application receipt date recorded by FDA.
P200046 · FDA decision
APPR
P200046/S052 · Related supplement
Harmony TPV System
Timeline entries are records held by MedtechLedger for P200046. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P200046
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Harmony TPV SystemP200046/S052 | Medtronic, Inc. | PMA supplement | Sep 30, 2026 | FDA |
Explore the linked device profile
Other records with product code NPV
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Edwards Lifesciences, LLC | PMA supplement | Oct 28, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Oct 27, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Sep 23, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA approval | Aug 31, 2020 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Medtronic, Inc.
- Headquarters
- Not reported
- Brand website
- medtronic.com
- FDA applicant address
- 3576 Unocal Pl., Bldg. A, Santa Rosa, CA, 95403
Sources and methodology
- Original FDA record: P200046
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

